(INSM) Insmed - Performance 164.9% in 12m
Compare INSM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
54.03%
#12 in Group
Rel. Strength
98.45%
#121 in Universe
Total Return 12m
164.92%
#5 in Group
Total Return 5y
312.66%
#9 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -4.99%
(unknown) Percentile in Group
12m Total Return: INSM (164.9%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-4.65% | 17.9% | 229% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-0.86% | 32.9% | 221% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-1.23% | 27.5% | 43.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-0.3% | 16.4% | 70.8% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.03% | -0.49% | 38.3% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.85% | 21.5% | 13.9% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
-4.86% | 15.4% | 6.78% | 27 | 25 | 1 | 58.7% | 15% |
| ERF PA Eurofins Scientific SE |
0.82% | -17.5% | 16.4% | 23.9 | 12.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: INSM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for INSM
| Total Return (including Dividends) | INSM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -3.88% | -8.71% | -7.79% |
| 3 Months | 4.97% | -15.44% | -9.06% |
| 12 Months | 164.92% | -14.04% | 4.64% |
| 5 Years | 312.66% | -2.41% | 117.94% |
| Trend Score (consistency of price movement) | INSM | XBI | S&P 500 |
| 1 Month | 7.90% | -62.6% | -5.5% |
| 3 Months | 22.2% | -73% | -61.9% |
| 12 Months | 67.9% | -8.4% | 82.8% |
| 5 Years | 18.6% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #51 | 5.29% | 4.24% |
| 3 Month | #24 | 24.1% | 15.4% |
| 12 Month | #5 | 208% | 153% |
| 5 Years | #10 | 323% | 89.4% |
FAQs
Does INSM Insmed outperforms the market?
Yes,
over the last 12 months INSM made 164.92%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.04%.
Over the last 3 months INSM made 4.97%, while XBI made -15.44%.
Over the last 3 months INSM made 4.97%, while XBI made -15.44%.
Performance Comparison INSM vs Indeces and Sectors
INSM vs. Indices INSM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.25% | 3.91% | 7.58% | 160% |
| US NASDAQ 100 | QQQ | 0.82% | 5.32% | 8.83% | 162% |
| US Dow Jones Industrial 30 | DIA | -1.42% | 2.16% | 5.48% | 160% |
| German DAX 40 | DAX | -1.37% | 2.44% | -11.3% | 147% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.97% | -3.08% | 17.8% | 157% |
| Hongkong Hang Seng | HSI | -3.76% | -4.86% | 11.1% | 148% |
| India NIFTY 50 | INDA | -4.43% | -11.0% | 12.8% | 165% |
| Brasil Bovespa | EWZ | -5.61% | -13.0% | 8.42% | 176% |
INSM vs. Sectors INSM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.59% | 4.22% | -0.82% | 152% |
| Consumer Discretionary | XLY | 0.45% | 5.75% | 4.57% | 158% |
| Consumer Staples | XLP | -7.11% | -2.60% | 0.38% | 152% |
| Energy | XLE | 0.99% | -3.42% | 7.22% | 173% |
| Financial | XLF | -0.65% | 3.61% | -4.38% | 149% |
| Health Care | XLV | -4.34% | 0.06% | 7.44% | 164% |
| Industrial | XLI | -0.31% | 2.19% | 8.42% | 163% |
| Materials | XLB | -1.50% | 0.15% | 14.1% | 174% |
| Real Estate | XLRE | -4.14% | 1.72% | 7.92% | 155% |
| Technology | XLK | 2.09% | 6.68% | 14.8% | 170% |
| Utilities | XLU | -7.56% | -4.07% | 4.30% | 140% |
| Aerospace & Defense | XAR | -0.63% | -0.49% | 2.64% | 150% |
| Biotech | XBI | 3.03% | 4.83% | 21.8% | 179% |
| Homebuilder | XHB | 1.44% | 3.06% | 27.7% | 180% |
| Retail | XRT | 0.80% | 4.65% | 14.3% | 176% |